Get the latest PM&R-specific news and information from your Academy. Read our peer-reviewed Journal or our member e-newsletters. Be sure to check out our newsfeed for real-time updates 24/7.
uroMedics Pharma LLC Issues Voluntary Nationwide Recall of Levofloxacin in 5% Dextrose 250mg/50mL Due to Presence of Visible Particulate Matter Tentatively Identified as Mold
Center for Medicare and Medicaid Services (CMS) Data Submission Rollout Announcement
FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older